President
Katrina Campion
GlaxoSmithKline
My involvement in Clinical Research began more than 20 years ago. Prior to joining the Therapeutics Industry 15 years ago, I worked for 5 years as a Research Assistant/Study co-ordinator in epidemiology and preventive medicine at Monash University. Like many others I did not have a career plan in mind on leaving school. It was luck rather than good planning that allowed me to combine my undergraduate qualifications in Sociology and History (BA) and an accelerated registered nursing qualification! During this period I also completed a Graduate Diploma and Master of Arts Degree during this time and went on to also study in areas of computing and public health. In 1993 I joined Glaxo as a Clinical Research Associate. During my years at GSK, I have worked primarily as Clinical Research Manager across therapy areas and been responsible for trials through all phases. During 1998, I spent time working in our global head office in London as a Medical Communications Scientist and on my return to Australia in 1999 had the privilege of hosting the FDA whilst they audited a key registration trial which I had driven from inception to publication. Over the last few years I have also had the opportunity to be involved in activities in Japan and India which have enabled me to develop a hands on appreciation of the challenges of conducting global registration trials outside of ANZ.
Vice President
Adrian Bootes
Roche Products Pty Ltd
Adrian holds graduate and post-graduate qualifications in pharmacy, and an MBA. He has extensive experience in the industry in both regulatory affairs and clinical research. He has held a number of positions with ARCS including membership of the Regulatory Education Subcommittee and later Regulatory convenor, was subsequently elected to ARCS Council for four years (1996 – 1999) and held Council positions as Education Convenor for two years during which time the educational programme was substantially broadened, and subsequently established the ARCS' web site whilst Internet Site Convenor. Upon re-election to Council in November 2004 he has worked for the last two years within the Member Services, Internal Audit and Finance subcommittees. Adrian has completed the Essential Directors Course, Modules 1 and 2, run by the AICD, and has been a keen contributor to ensure the continued growth and financial stability of the organisation.
Directors
James Bryden
Abbott Australasia
James has been a member of the Pharmaceutical industry since 1994, joining as a CRA within a Contract Research Organisation (Pharmaco::LSR). He has since gained experience as CRA, Senior CRA, and Clinical Research Manager with both Pharma company (3M Pharmaceuticals) and a CRO (Trident Clinical Research). Working in both CRO and Pharma company environments, has given James a broad experience in many therapeutic and speciality areas such as pharmaceutical products, biopharmaceuticals, devices, and nutritional studies. James’ particular interest is in project and personnel management.
Amanda Jubb
Amanda has 15 years experience of clinical research roles within the pharmaceutical industry. With a core foundation as a CRA Amanda has worked predominantly in line management roles coordinating teams and projects locally and across the Asia Pacific region. Amanda has been exposed to various business set-ups and styles including global and local organisations, manufacturing companies and CROs. Amanda has represented her functional area on internal management teams and has benefited from completion of four of the AICD training courses.
Sumith Nawaratne
Hospira Australia
My educational background includes a BSc (Hons) from Monash University in Pharmacology and a PhD from the Victorian College of Pharmacy/Austin Hospital in Clinical Pharmacology and Pharmacokinetics. I have been engaged in clinical research, project management and medical marketing for the last 14 years. In that time I have worked for CSL, PPD, Mayne Pharma and Hospira Australia. I was also the project manager for the Australia Thai HIV vaccine Consortium, for which I was responsible for the GLP, GMP and GCP development of two HIV vaccine candidates. As a consequence I have gained experience in all areas of pharmaceutical/biotechnology product development from conception to market approval/medical marketing, with my strength in clinical development. In addition, I co-founded the Austin Hospital Radiology research unit and committee which have now been operational for over 10 years, for which I remain an active member. During my time in the pharmaceutical industry, I have held concurrent appointments as a Senior Fellow in both the Radiology and Microbiology/Immunology departments of Melbourne University. I am a current member of the Australian Institute of Company Directors and a Fellow of the Australian Institute of Project Managers.
Sian Slade
Consultant
A pharmacist by background with a Masters in Business Administration, Siân has applied both pharmacy and business experience to roles within the pharmaceutical industry over a period of eighteen years. Roles have covered a variety of functions including clinical development, medical affairs, commercial and human resources at country (UK, Australia) and regional level (Europe, Middle East & Africa). Sian is c
urrently running a consulting business which serves to deliver output and add value to clients. Responsibilities include accounting and tax responsibilities and legal contracting for the business which includes provision of coaching support (related to both functional and behavioural competences), strategic support and tactical support.
Siân has been active in the Melbourne ESC of ARCS and will use her broad cross-functional experience base together with dynamic and tenacious approach to deliver outputs focused on helping ARCS deliver to agreed, set objectives. Siân will draw on skills in business development, marketing, communications and HR, to add value to ARCS – both in terms of further building their profile at both a national professional, and also international level and will use analytical skills eg review of return on investment, to ensure future long term financial health of ARCS to be able to achieve long term strategic objectives.
Andrew Taylor
Roche Products Pty Ltd
Andrew has worked in the pharmaceutical industry since 1988, including eight years in Australia. During this time, Andrew has gained experience in IT and drug development in both international pharmaceutical companies and with a global CRO. In his current role, Andrew manages the Dee Why (Sydney) Clinical Management Group (~60 staff). Responsible for staff delivering all global clinical project management and data management activities for Pharmaceutical Development clinical studies. Also responsible for staff delivering data management activities for Asia-Pacific and local Medical Marketing studies. These responsibilities include budget management, performance management, staff wellbeing and development, study delivery and quality.
Gillian Waddel
Mulbrae Clinical Strategies
Gillian has a degree in Pharmacy and over 25 years experience in clinical research, gained both in Europe and Australia. She has held various positions including Clinical Research Manager for two leading international pharmaceutical companies. For the last five years, Gillian has been running her own management consultancy company in clinical research called Mulbrae Clinical Strategies. In this role, she has worked with a number of pharmaceutical companies both, large international companies and small start up companies. Thus, this experience, has provided her with opportunities to interact with many ARCs members and gain a real insight into their varying needs.